Found 187 results in Expert Content

Summary: Listen in as experts Sherief Shaaban from Catalent and Kurt von Emster of Abingworth discuss taking a drug from concept to a tangible solution with a renewed focus on milestones, timelines, and efficiencies. Learn how biotechs are reconsidering strategic partnerships to better navigate development pathways, accelerate timelines, avoid common pitfalls, and stretch limited capital further than before.

Summary: This article examines critical aspects of formulation development for spray-dried powders and the risk mitigation strategies that may be applied to address a range of common issues during production.

An advanced development offering that integrates formulation expertise with on-demand Phase 1 clinical manufacturing, adaptive clinical testing and regulatory support, to help achieve flexible and efficient First-in-Human studies and expedited development.

Summary: In this executive summary, learn how to gather the right team to translate benchtop discoveries into clinical trials, and more.

Hear from a panel of experts on the critical challenges of spray dried powder formulation development, risk mitigation strategies and more.

Summary: In this webinar, experts will explore the journey from molecule candidate selection to first-in-human clinical studies, discussing the process from initial formulation conception to forming accelerated pathways to clinical trials.

Summary: Join this webcast to hear a panel of drug developers discuss how innovative trial designs, on-demand manufacturing, real-time clinical data-based dose adjustments and partnering with experienced formulators and Contract Research Organizations (CROs) can enable faster, better decision making during phase 1 clinical trials.

Summary: In this exclusive webinar designed for drug developers and pharmaceutical and biotechnology consultants, experts review the importance of the Target Product Profile (TPP).

Summary: Insights into the spray drying process and learn how a robust scale-up methodology can be used to progress spray dry formulations from pilot scale to commercial scale production.

Summary: A panel of drug developers discuss innovative trial designs, on-demand manufacturing, communicating between clinical partners, prepping a strong regulatory submission and enabling faster decision making in your phase I trial.